Suppr超能文献

阿根廷跨性别女性对艾滋病毒暴露前预防用药的高使用意愿

High Willingness to Use HIV Pre-Exposure Prophylaxis Among Transgender Women in Argentina.

作者信息

Zalazar Virginia, Arístegui Inés, Kerr Thomas, Marshall Brandon D L, Romero Marcela, Sued Omar, Socías M Eugenia

机构信息

Fundación Huésped, Buenos Aires, Argentina.

Universidad de Palermo, Buenos Aires, Argentina.

出版信息

Transgend Health. 2016 Dec 1;1(1):266-273. doi: 10.1089/trgh.2016.0033. eCollection 2016.

Abstract

In Argentina, transgender women face a disproportionately high prevalence of HIV infection (34%). Although not currently approved in Argentina, pre-exposure prophylaxis (PrEP) may offer a potential effective HIV prevention tool for this population. In this study, we assessed the willingness to use PrEP among transgender women in Argentina. Data were drawn from a nationwide cross-sectional survey conducted among transgender women in 2013. Using multivariable logistic regression, we assessed the prevalence of and factors associated with willingness to use PrEP among transgender women with negative or unknown HIV status. This study included 337 transgender women (278 HIV negative and 59 with unknown HIV status), most of whom had a history of sex work involvement (81.8%). Overall, 301 (89.3%) expressed willingness to use PrEP. In a multivariable analysis, having casual sexual partners was positively associated with willingness to use PrEP (adjusted odds ratio [AOR]=4.26, 95% confidence interval [CI] 1.73-10.51), while discrimination by healthcare workers was negatively associated (AOR=0.33, 95% CI 0.12-0.88). We found high levels of willingness to use PrEP among transgender women in Argentina, suggesting that there is high perception of HIV risk in this population. However, discrimination by healthcare workers was a strong negative correlate of willingness to use PrEP, suggesting that multilevel interventions that address gender-based stigma in healthcare settings will be critical for the success of PrEP as an HIV prevention strategy in this population.

摘要

在阿根廷,跨性别女性感染艾滋病毒的比例极高(34%)。虽然暴露前预防(PrEP)目前在阿根廷尚未获批,但它可能为这一人群提供一种潜在有效的艾滋病毒预防工具。在本研究中,我们评估了阿根廷跨性别女性使用PrEP的意愿。数据来自2013年对跨性别女性进行的一项全国性横断面调查。我们使用多变量逻辑回归,评估了艾滋病毒检测呈阴性或状况不明的跨性别女性中使用PrEP意愿的患病率及相关因素。本研究纳入了337名跨性别女性(278名艾滋病毒检测呈阴性,59名状况不明),其中大多数有性工作经历(81.8%)。总体而言,301名(89.3%)表示愿意使用PrEP。在多变量分析中,有临时性伴侣与使用PrEP的意愿呈正相关(调整后的优势比[AOR]=4.26,95%置信区间[CI]为1.73 - 10.51),而医护人员的歧视则呈负相关(AOR=0.33,95%CI为0.12 - 0.88)。我们发现阿根廷的跨性别女性对使用PrEP的意愿很高,这表明该人群对艾滋病毒风险的认知度很高。然而,医护人员的歧视是使用PrEP意愿的一个强烈负相关因素,这表明解决医疗环境中基于性别的污名化问题的多层次干预措施对于PrEP作为该人群艾滋病毒预防策略的成功实施至关重要。

相似文献

1
High Willingness to Use HIV Pre-Exposure Prophylaxis Among Transgender Women in Argentina.
Transgend Health. 2016 Dec 1;1(1):266-273. doi: 10.1089/trgh.2016.0033. eCollection 2016.
3
Awareness and Willingness to use HIV Pre-exposure Prophylaxis (PrEP) Among Trans Women in China: A Community-Based Survey.
AIDS Behav. 2021 Mar;25(3):866-874. doi: 10.1007/s10461-020-03050-6. Epub 2020 Sep 28.
4
PrEP awareness and engagement among transgender women in South Africa: a cross-sectional, mixed methods study.
Lancet HIV. 2020 Dec;7(12):e825-e834. doi: 10.1016/S2352-3018(20)30119-3. Epub 2020 Jul 2.
6
Factors Influencing Willingness to Use Human Immunodeficiency Virus Preexposure Prophylaxis Among Transgender Women in India.
Transgend Health. 2021 Apr 16;6(2):64-73. doi: 10.1089/trgh.2019.0076. eCollection 2021 Apr.
7
10

引用本文的文献

1
A scoping review examining measurement of anti-transgender stigma in low- and middle-income countries.
PLOS Glob Public Health. 2025 Apr 30;5(4):e0004490. doi: 10.1371/journal.pgph.0004490. eCollection 2025.
4
HIV Risk Perception and Pre-Exposure Prophylaxis (PrEP) Awareness Among Transgender Women from Mexico.
AIDS Behav. 2023 Mar;27(3):992-1002. doi: 10.1007/s10461-022-03836-w. Epub 2022 Sep 19.
5
Factors Influencing Willingness to Use Human Immunodeficiency Virus Preexposure Prophylaxis Among Transgender Women in India.
Transgend Health. 2021 Apr 16;6(2):64-73. doi: 10.1089/trgh.2019.0076. eCollection 2021 Apr.
6
10
The HIV epidemic in Latin America: accomplishments and challenges on treatment and prevention.
Curr Opin HIV AIDS. 2019 Sep;14(5):366-373. doi: 10.1097/COH.0000000000000564.

本文引用的文献

1
'I am not a man': Trans-specific barriers and facilitators to PrEP acceptability among transgender women.
Glob Public Health. 2016 Aug-Sep;11(7-8):1060-75. doi: 10.1080/17441692.2016.1154085. Epub 2016 Mar 10.
3
Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice.
Curr Opin HIV AIDS. 2016 Jan;11(1):10-7. doi: 10.1097/COH.0000000000000220.
4
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.
N Engl J Med. 2015 Dec 3;373(23):2237-46. doi: 10.1056/NEJMoa1506273. Epub 2015 Dec 1.
5
HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.
Lancet HIV. 2015 Dec;2(12):e512-9. doi: 10.1016/S2352-3018(15)00206-4. Epub 2015 Nov 6.
6
Prevalence and Correlates of Lifetime Suicide Attempts Among Transgender Persons in Argentina.
J Homosex. 2016 Jul;63(7):955-67. doi: 10.1080/00918369.2015.1117898. Epub 2015 Nov 13.
8
Correlates of PrEP Indication in a Multi-Site Cohort of Young HIV-Uninfected Transgender Women.
AIDS Behav. 2016 Jul;20(7):1470-7. doi: 10.1007/s10461-015-1182-z.
9
How Stigma Surrounding the Use of HIV Preexposure Prophylaxis Undermines Prevention and Pleasure: A Call to Destigmatize "Truvada Whores".
Am J Public Health. 2015 Oct;105(10):1960-4. doi: 10.2105/AJPH.2015.302816. Epub 2015 Aug 13.
10
Inclusion of trans women in pre-exposure prophylaxis trials: a review.
AIDS Care. 2015;27(5):637-41. doi: 10.1080/09540121.2014.986051. Epub 2014 Nov 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验